Invesco Ltd. - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-50.0%
12,350
+1.1%
0.00%
Q4 2021$58,000
-50.4%
12,212
-17.1%
0.00%
Q3 2021$117,000
+30.0%
14,726
+12.9%
0.00%
Q2 2021$90,000
-84.5%
13,045
-79.2%
0.00%
Q2 2020$580,000
+130.2%
62,668
+138.0%
0.00%
Q3 2018$252,000
-34.0%
26,333
-27.0%
0.00%
Q2 2018$382,00036,0630.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders